Materials • Major Chemicals
$5.69 ▼ -0.11
(-1.90%)
MKT CAP: $249.6M • VOL: 478.5K
52W L $3 52W H $7
FF // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $95.7M | $243.3M | $368.3M |
| YoY Revenue Growth % | -60.7% | -33.9% | — |
| Gross Profit | -$39.4M | $19.6M | — |
| Gross Margin % | -41.2% | 8.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$53.0M | $6.4M | $27.4M |
| Operating Margin % | -55.3% | 2.6% | 7.4% |
| Net Income (GAAP) | -$49.4M | $15.5M | $37.4M |
| EBITDA (Normalized) | -$39.2M | $18.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$28.7M | $24.8M | $21.3M |
| Capital Expenditures (CapEx) | $17.2M | $14.7M | — |
| Free Cash Flow (FCF) | -$46.0M | $10.1M | $21.3M |
| FCF Margin % | -48.0% | 4.2% | 5.8% |
| Return on Invested Capital (ROIC %) | -37.6% | 5.2% | — |
| Cash & Short-Term Equivalents | $51.3M | $109.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $162.6M | $205.8M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR FF.